---
url: https://www.servicesaustralia.gov.au/non-infectious-uveitis
title: Non-infectious uveitis - Health professionals - Services AustraliaServices AustraliaServices Australia
scrapedAt: 2026-02-20T21:41:24.097Z
source: servicesaustralia.gov.au
---
# Non-infectious uveitis

The PBS subsidises adalimumab for patients with non-infectious uveitis.

## on this page

-   [Patient eligibility](#a1)
-   [Treatment specifics](#a2)
-   [Authority applications](#a3)
-   [More information](#a4)

Please note: You’ll get an immediate assessment when you request [PBS authorities online](/apply-for-pbs-authority?context=20#accordion1).

## Patient eligibility

The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with adalimumab under the _National Health Act 1953_, section 85 for patients with non-infectious uveitis.

Patients must be eligible for the [PBS](/pharmaceutical-benefits-scheme) and meet the relevant restriction criteria.

The [Schedule of Pharmaceutical Benefits](http://www.pbs.gov.au/pbs/home) on the PBS website outlines the restrictions for prescribing adalimumab.

## Treatment specifics

To be eligible for PBS-subsidised treatment with adalimumab, patients must be treated by, or in consultation with either:

-   an ophthalmologist
-   a rheumatologist
-   an immunologist with expertise in uveitis.

## Authority applications

### Applying for initial treatment

Applications for initial authority approval to prescribe PBS-subsidised adalimumab to treat non-infectious uveitis can be made either in:

-   real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [non-infectious uveitis - adalimumab - initial authority application form](/pb372?context=20)
-   relevant attachments.

### Applying for recommencement of treatment

Applications to recommence authority approval to prescribe PBS-subsidised adalimumab to treat non-infectious uveitis can be made either:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   by calling the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs).

### Applying for continuing treatment

Applications for continuing authority approval to prescribe PBS-subsidised originator brand of adalimumab to treat non-infectious uveitis can be made either:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   by calling the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs).

Application for continuing PBS-subsidised treatment with biosimilar brands of adalimumab is Authority Required (Streamlined). You don’t need authority approval from us for the listed quantities and repeats.

## More information

Call the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs) for more information.
